Fifty million Indians suffer from fungal diseases
More than 50 million Indians suffer from fungal diseases and 10% belong to the potentially dangerous mould infections, according to researchers from New.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
More than 50 million Indians suffer from fungal diseases and 10% belong to the potentially dangerous mould infections, according to researchers from New.
Bharat Biotech, an Indian developer of vaccines for infectious diseases, will roll out its nasal Covid-19 vaccine for patients above 18 years in.
The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest.
India is releasing a beta version of the hospital management information system focusing on private clinics and smaller health facilities.
Drug regulators started investigating Marion Biotech after Uzbekistan alleged 18 children died in Samarkand city following the consumption of cough syrup made by.
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.
Samples of Indian cough syrups, linked to the deaths of 66 children in Gambia, complied with government specifications and were not contaminated.
Indian drugmaker Sun Pharmaceutical Industries, facility in western Gujarat state, has been listed by the Food & Drug Administration under "import alert," according.
India has been experiencing severe heat waves over the last few decades, and they are sweeping across earlier and staying longer, a trend.
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.